Avant Biomedical

Avant Biomedical

A producer of biotechnology and medical goods, used by the Marines.

• Hyposprays
• Blood substitutes

Avant Biomedical is a large corporation focused on the production of medical technology, pharmaceuticals, and biotech. Its heavy focus on medical goods has led to it having significant competition with Weston-Yamada as both groups attempt to out-perform the other in new equipment, supplies, and biotechnology products.

Early History

Avant Biomedical started its life as a small-scale Arachnid-formed Biotechnology corporation, focused on medical and agricultural research. Despite its smaller size, Avant would develop a few notable projects at this time, such as vaccines for extrasolar diseases and resilient strains of fruits and vegetables.

Avant would soon find itself in the public spotlight following a series of genetic experiments and research which resulted in the creation of the human subspecies Homo sapiens feliinae, more commonly known as Felinids. The project was intended to just instill notable beneficial traits present in felines, but would result in the aforementioned cat-human hybrids, much to the shock of the researchers and volunteers alike. Although Avant was quick to issue an apology, critics expressed suspicion that the higher-ups were aware of the risks but did not inform the volunteers or their scientists, which resulted in several lawsuits being filed against the company.

However, Avant’s fortunes would turn for the better following a series of mass-layoffs of Weston-Yamada’s R&D Medical Research and Biotechnology Departments, as well as a mass-termination of Novaris engineers for quarterly cost-cutting. Avant, realizing the need for expansion to maintain profit margins, was quick to utilize this opportunity, employing many of these scientists, engineers, and executives for their own purposes.

Decisive business choices, as well as several investments from wealthy shareholders, would lead to Avant quickly becoming a leader in the Biotechnology industry.

Recent Efforts

Avant Biomedical has seen multiple key projects enacted in recent years in an attempt to further its influence and power within the Corporate World. Recent developments have seen Avant roll out various artificially-grown limbs and organs for use in transplants at relatively cheap prices, although these are often unavailable on the frontier due to transporting costs making them all but unaffordable.

Avant has also produced various crops genetically edited to refine various toxic or heavy elements in planetary atmospheres into breathable air, serving as a more organic, albeit far slower, method of terraforming. Genetic editing and modification has remained an area of heavy investment for the Company, and Avant is always developing improved medical supplies and goods.

Avant is also the producer of Hyposprays and blood-bag machines, which it sells to both civilians and military groups, including the UNMC.

However, Avant has recently come under scrutiny from regulatory bodies such as the Interstellar Commerce Bureau, as well as from other Corporate entities due to a collection of shady operations and questionable ethical practices. The company is alleged to engage in covert sabotage operations against corporate rivals, and recent ICB inquiries, investigations, and reports, indicate that Avant may be involved in the production of biological weaponry. Avant’s spokespeople naturally deny these operations, often regarding them as paranoid rumor or the work of upset rivals and pointing towards Avant’s positive contributions to the medical world, although the Corporation remains hesitant to allow an open-inquiry into their operations.